--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About CDNA20260220C22.5
Healthcare Equipment and Supplies
CareDx, Inc., was incorporated in Delaware on December 21, 1998. The company is a commercial stage company that develops decision markets and provides heart transplants to patients to help clinicians diagnose, monitor solutions and personalize treatments. CareDx's first commercialized test protocol, AlloMap Molecular Test Heart Transplant, or AlloMap Blood-Based Test, is used to monitor acute cellular rejection after heart transplantation.
